G. Klinowski

OP0184 PREVALENCE OF SUBCLINICAL GIANT CELL ARTERITIS IN PATIENTS WITH POLYMYALGIA RHEUMATICA

A. Tomelleri, E. de Miguel, S. Monti, 2022, Annals of the Rheumatic Diseases.

POS0731 SOUTHEND GCA PROBABILITY SCORE (GCAPS) AND ULTRASOUND HALO SCORE (HS) AS MARKERS FOR DIAGNOSIS AND MONITORING OF GCA: RESULTS FROM THE PROSPECTIVE, MULTICENTER HAS-GCA STUDY

A. Tomelleri, C. Salvarani, P. Macchioni, 2023, Annals of the Rheumatic Diseases.

Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.

G. Hunder, A. Versari, E. Galli, 2023, Seminars in arthritis and rheumatism.

Rituximab for the treatment of acute onset Interstitial Lung Disease in primary Sjogren's syndrome.

E. Clini, M. Sebastiani, F. Gozzi, 2021, Pulmonology.

Prevalence and characteristics of subclinical giant cell arteritis in polymyalgia rheumatica.

A. Tomelleri, C. Campochiaro, E. de Miguel, 2023, Rheumatology.

Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.

A. Tomelleri, C. Campochiaro, E. de Miguel, 2023, Annals of the rheumatic diseases.